Emerging roles are being recognized increasingly for apolipoproteins in the pathogenesis
and treatment of lung diseases on the basis of their ability to suppress inflammation …

Apolipoprotein AI (apoA-I) and high-density lipoproteins (HDL) mediate reverse cholesterol
transport out of cells. Furthermore, HDL has additional protective functions, which include …

COPD is a clinically heterogeneous syndrome characterized by injury to airways, airspaces,
and lung vasculature and usually caused by tobacco smoke and/or air pollution exposure …

Respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD)
are characterised by excessive and persistent inflammation. Current treatments are often …

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent lung diseases.
Cigarette smoking is the main risk factor for COPD. In this parallel-group clinical study we …

Plasma is the most easily accessible source for biomarker discovery in clinical proteomics.
However, identifying potential biomarkers from plasma is a challenge given the large …

High-density lipoproteins (HDL) are complexes of multiple talents, some of which have only
recently been recognised but all of which are under active investigation. Clinical interest …

Human saliva, a multi-constituent oral fluid, has a high potential for early diagnosis of
disease. Proteomic analysis of saliva holds promise as a non-invasive method that is …

Although there is increasing interest in using pulmonary biomarkers for a more complete
and clinically relevant assessment of COPD and a plethora of biomarkers are becoming …

From an evolutionary perspective, lipoproteins are not only lipid transporters, but they also
have important functions in many aspects of immunity. High-density lipoprotein (HDL) …